Briarcliff Manor, NY, United States of America

Sophia Huai Zhou

This inventor holds 16 USPTO granted patents and 5 published patent applications and 5 EPO patents, primarily in Cardiac Monitoring. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sophia Huai Zhou. Retrieved from https://idiyas.com/inventor/sophia-huai-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 84(Granted Patents)


Location History:

  • Caramillo, CA (US) (2012)
  • Camarillo, CA (US) (2013 - 2017)
  • Briarcliff Manor, NY (US) (2014 - 2019)
  • Cambridge, MA (US) (2018 - 2019)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Electrocardiogram
Spirogram Analysis
Sleep Quality
Atrial Fibrillation
Capnography
Coronary Artery
Myocardial Infarct
Patient Condition
Rhythm Analysis
Real-Time Monitoring
Ischemia Detection
Automated Diagnosis
16 patents (USPTO):Explore Patents

Title: Innovating Cardiac Diagnostics: The Contributions of Sophia Zhou

Introduction

Sophia Zhou is a pioneering inventor based in Caramillo, California, recognized for her groundbreaking contributions to the field of cardiac diagnostics. With a focus on enhancing the accuracy of diagnosing acute ischemic events, Zhou has successfully obtained a patent that exemplifies her innovative spirit and technical expertise.

Latest Patents

Sophia Zhou holds a patent titled "Automated Identification of Culprit Coronary Artery." This invention introduces an advanced diagnostic ECG system that analyzes lead traces for evidence of ST elevation in the lead signals. By examining patterns of ST elevation and ST depression in specific leads related to the heart's electrical activity, the system accurately identifies the culprit coronary artery involved in an acute ischemic event. This technology not only aids interventional cardiologists by guiding them to the correct coronary artery for treatment but also utilizes standard 12-lead ECG systems and those with varying lead configurations, showcasing its versatility and applicability in a clinical setting.

Career Highlights

Sophia Zhou is currently employed at Koninklijke Philips Corporation N.V., a leading multinational in health technology. Within this esteemed corporation, she continues to develop cutting-edge solutions that push the boundaries of medical technology and patient care. Her commitment to improving cardiovascular diagnostics through innovation marks a significant milestone in her career.

Collaborations

Throughout her career, Zhou has collaborated with distinguished colleagues, including Shankar Reddy and Richard Earl Gregg. These partnerships have allowed her to merge ideas and expertise, driving advancements in the field of diagnostics further and contributing to the development of innovative health technologies.

Conclusion

Sophia Zhou's pioneering work in the development of diagnostic ECG systems underscores the importance of innovation in addressing complex medical challenges. With her patented technique for identifying culprit coronary arteries, Zhou has made a substantial impact on cardiac care, providing vital tools for interventional cardiologists. Her contributions not only enhance diagnostic accuracy but also represent a significant advancement in the fight against cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…